42
Growth Score
pts
Heat Score
-25 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
490352
AEROGEN PHARMA is a clinical-stage specialty pharmaceutical company developing proprietary inhaled medications.
- David Durand: Chief Medical OfficerPast Role: UCSF Benioff Children’s Hospital Oakland, Chief Medical Officer
About the Company
AEROGEN PHARMA is a clinical-stage specialty pharmaceutical company developing proprietary inhaled medications. The company creates medically superior, proprietary, and commercially differentiated combination products by combining proven therapeutic molecules with a unique, high-performance aerosol delivery system. AEROGEN PHARMA approach is
optimized for quick, efficient, consistent, and user-friendly delivery of liquid medications to patients on a broad range of oxygen and ventilator support equipment.
Its company's headquarters is located in Galway, Ireland and San Mateo, California.
